Stay updated on Sofosbuvir/Velpatasvir vs Ribavirin in HCV Clinical Trial
Sign up to get notified when there's something new on the Sofosbuvir/Velpatasvir vs Ribavirin in HCV Clinical Trial page.

Latest updates to the Sofosbuvir/Velpatasvir vs Ribavirin in HCV Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedAdded site revision tag v3.4.2 and removed the earlier government-funding notice; this is an administrative update and does not affect study content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check22 days agoChange DetectedA site-wide notice about government funding lapses was added, with guidance to check cc.nih.gov and opm.gov for current status. The page revision was updated from v3.4.0 to v3.4.1.SummaryDifference0.4%

- Check29 days agoChange DetectedUI and metadata updates include a glossary toggle label, updated QC-related labels, No FEAR Act data text, and a revision/version change to v3.4.0 (replacing v3.3.4). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check43 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4 on the page footer. This change does not affect the study details, eligibility criteria, outcomes, or any user-facing content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check64 days agoChange DetectedFooter updates add Revision: v3.3.3 and remove HHS Vulnerability Disclosure and Revision: v3.3.2 from the footer. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check93 days agoChange DetectedThe site revision label in the footer updated from v3.2.0 to v3.3.2.SummaryDifference0.0%

Stay in the know with updates to Sofosbuvir/Velpatasvir vs Ribavirin in HCV Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Sofosbuvir/Velpatasvir vs Ribavirin in HCV Clinical Trial page.